Defying Stage IIIb Colon Cancer with Integrative Treatment
A Surprising Diagnosis
LG, a 55-year-old male, was diagnosed with stage IIIb colon cancer in February 2018 following routine blood tests for an unrelated condition.
Though he experienced no symptoms, a colonoscopy revealed a right-sided lesion that turned out to be Adenocarcinoma. Additional tests showed the cancer had spread to more than 10 lymph nodes, making the prognosis more serious.
Despite this, LG’s Carcinoembryonic Antigen (CEA) levels remained normal throughout treatment, and lung nodules that appeared on scans were not confirmed as cancerous.
Developing a Comprehensive Treatment Plan
LG’s journey is a testament to the power of a personalized, integrative approach. His treatment plan, crafted by Dr. Meakin, combined standard therapies, repurposed medications, and lifestyle changes:
1. Surgery : In early 2018, LG underwent surgery to remove the primary tumor and affected lymph nodes. This critical first step helped establish a foundation for his subsequent therapies.
2. Chemotherapy: Initially prescribed oral chemotherapy, LG experienced severe side effects and switched to a 6-month regimen of FOLFOX (folinic acid, fluorouracil, and oxaliplatin). Though intense, this regimen successfully targeted the remaining cancer cells.
3. Metabolic Repurposed Drugs: In 2019, LG began taking a combination of Metformin, Doxycycline, Atorvastatin, and Mebendazole drugs typically used for other conditions but shown to inhibit cancer cell growth. He continues to take Metformin and Atorvastatin to this day.
4. Additional Therapies: LG incorporated a lipophilic form of ibuprofen called Flarin, along with a variety of supplements like Vitamin D3, K2, Omega-3, and Coriolus versicolor. These additions helped support his immune system and overall health.
5. Lifestyle Changes: A strict Mediterranean diet, rich in healthy oils, vegetables, and lean proteins, complemented his treatment. He also adopted a rigorous exercise routine, working out six days a week with a mix of resistance training, cardio, and balance exercises.
Achieving No Evidence of Disease (NED)
LG’s unwavering commitment and holistic approach paid off. He has been in No Evidence of Disease (NED) status for 6 years—a remarkable outcome for stage IIIb colon cancer.
The Power of Lifestyle and Integrative Therapies
LG’s experience highlights the critical role of lifestyle modifications in cancer management. Research supports that a Mediterranean diet and regular exercise can significantly improve survival rates and reduce cancer recurrence.
Repurposed drugs, such as Mebendazole and Metformin, have also shown potential in enhancing treatment effectiveness by targeting cancer metabolism.
“LG’s journey is a testament to the power of combining conventional therapies with integrative strategies. By focusing on metabolic health, lifestyle modifications, and repurposed medications, we were able to not only target the cancer but also support his overall well-being. This approach allowed him to achieve lasting remission and a high quality of life.” — Dr. Charles Meakin
